Method of monomerizing human serum albumin polymers
CA 2395587 C · Owner: Tanabe, Tetsuro · Inventors: Miyatsu, Yoshinobu; Adachi, Satoshi; Tanabe, Tetsuro
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method for converting a multimer of human serum albumin into monomers thereof comprises the step of treating the multimer with an alkaline solution. This method permits the efficient and quite simple conversion of human serum albumin multimers into monomers thereof at a low cost. A method for preventing the uncorrected holding of human serum albumin during a process for converting a multimer of human serum albumin into monomers thereof by treating the multimer with an alkaline solution, comprises the step of treating the human serum albumin-containing solution with the alkaline solution in the presence of an SH group-containing compound. This method permits the efficient …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 24, 2001 and granted September 18, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 24, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 24, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.